Tenderwize
Back to tender search

Delivery of Teprotumumab medicinal product

UNIWERSYTECKI SZPITAL KLINICZNY IM. JANA MIKULICZA-RADECKIEGO WE WROCŁAWIU·WROCŁAW, Poland·Expired · Jul 24, 2026·Open·Supplies
Original notice title

Poland – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – DZP.242.268.2026 - Dostawa produktu leczniczego – Teprotumumab

0/100

Opportunity Score

High riskLow complexity
SuppliesExpired
Why this score?

Opportunity

0 / 100

Complexity

0 / 100

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Tender facts

Contracting authority
UNIWERSYTECKI SZPITAL KLINICZNY IM. JANA MIKULICZA-RADECKIEGO WE WROCŁAWIU
Country
Poland
CPV
33650000 - General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
Deadline
Jul 24, 2026

AI tender analysis

Tenderwize prepares an AI analysis of this tender based on the TED notice and procurement documents: scope of work, key requirements, eligibility criteria, risks and questions for the buyer. The analysis is generated when the tender is opened.

Award Criteria

Lot 1

Cena — 100%

Buyer

Location

WROCŁAW, POL

Buyer profile

Open profile

Identifier

8981816856

Activity

Health

Lots (1)

LOT-0001

Dostawa produktu leczniczego – Teprotumumab

Dostawa produktu leczniczego – Teprotumumab - 1 ZADANIE

SuppliesEU fundedElectronic submission

PLN 668.1k

Estimated value

Location

PL514, Poland

Duration

6 MONTH

Category

Anti-infectives for systemic use

Award Criteria

Cena

Procurement Details

Publication date
24 Jun 2026
Languages
Polish

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
433146-2026

Documents (1)

Similar tenders